Immaturity of Human Stem-Cell-Derived Cardiomyocytes in Culture: Fatal Flaw or Soluble Problem?

Stem Cells and Development

Volumn 24, Issue 9, 2015, Pages 1035-1052

  Veerman, Christiaan C ^a   Kosmidis, Georgios ^b   Mummery, Christine L ^b   Casini, Simona ^a,b   Verkerk, Arie O ^a   Bellin, Milena ^b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM;

ADRENERGIC STIMULATION; CELL CULTURE; CELL MATURATION; COCULTURE; ELECTRIC ACTIVITY; ELECTRIC CONDUCTIVITY; ELECTROPHYSIOLOGY; ELECTROSTIMULATION; EXCITATION CONTRACTION COUPLING; GENE EXPRESSION; HEART MUSCLE CELL; HUMAN; HUMAN STEM CELL DERIVED CARDIOMYOCYTE; MECHANICAL STRESS; METABOLISM; NONHUMAN; PRIORITY JOURNAL; REVIEW; SARCOMERE; CARDIAC MUSCLE CELL; CELL DIFFERENTIATION; CYTOLOGY; PHYSIOLOGY; PLURIPOTENT STEM CELL; PRIMARY CELL CULTURE; PROCEDURES; TRANSPLANTATION;

CELL DIFFERENTIATION; HUMANS; MYOCYTES, CARDIAC; PLURIPOTENT STEM CELLS; PRIMARY CELL CULTURE;

EID: 84934292637     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2014.0533     Document Type: Review

References (162)

1. Nichols M, N Townsend, P Scarborough and M Rayner. (2013). Cardiovascular disease in Europe: epidemiological update. Eur Heart J 34:3028-3034.
2. Go AS, D Mozaffarian, VL Roger, EJ Benjamin, JD Berry, MJ Blaha, S Dai, ES Ford, CS Fox, et al. (2014). Executive summary: heart disease and stroke statistics-2014 update: a report from the American Heart Association. Circulation 129:399-410.
3. Bellin M, MC Marchetto, FH Gage and CL Mummery. (2012). Induced pluripotent stem cells: the new patient? Nat Rev Mol Cell Biol 13:713-726.
4. Fox IJ, GQ Daley, SA Goldman, J Huard, TJ Kamp and M Trucco. (2014). Stem cell therapy. Use of differentiated pluripotent stem cells as replacement therapy for treating disease. Science 345:1247391.
5. Takahashi K, K Tanabe, M Ohnuki, M Narita, T Ichisaka, K Tomoda and S Yamanaka. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131:861-872.
6. Yu J, MA Vodyanik, K Smuga-Otto, J Antosiewicz-Bourget, JL Frane, S Tian, J Nie, GA Jonsdottir, V Ruotti, et al. (2007). Induced pluripotent stem cell lines derived from human somatic cells. Science 318:1917-1920.
7. Musunuru K. (2013). Genome editing of human pluripotent stem cells to generate human cellular disease models. Dis Model Mech 6:896-904.
8. Chong JJ, X Yang, CW Don, E Minami, YW Liu, JJ Weyers, WM Mahoney, BB Van, NJ Palpant, et al. (2014). Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts. Nature 510:273-277.
9. Yang X, L Pabon and CE Murry. (2014). Engineering adolescence: maturation of human pluripotent stem cellderived cardiomyocytes. Circ Res 114:511-523.
10. Sartiani L, E Bettiol, F Stillitano, A Mugelli, E Cerbai and ME Jaconi. (2007). Developmental changes in cardiomyocytes differentiated from human embryonic stem cells: a molecular and electrophysiological approach. Stem Cells 25:1136-1144.
11. Lundy SD, WZ Zhu, M Regnier and MA Laflamme. (2013). Structural and functional maturation of cardiomyocytes derived from human pluripotent stem cells. Stem Cells Dev 22:1991-2002.
12. Ivashchenko CY, GC Pipes, IM Lozinskaya, Z Lin, X Xiaoping, S Needle, ET Grygielko, E Hu, JR Toomey, JJ Lepore and RN Willette. (2013). Human-induced pluripotent stem cell-derived cardiomyocytes exhibit temporal changes in phenotype. Am J Physiol Heart Circ Physiol 305:H913-H922.
13. Kamakura T, T Makiyama, K Sasaki, Y Yoshida, Y Wuriyanghai, J Chen, T Hattori, S Ohno, T Kita, et al. (2013). Ultrastructural maturation of human-induced pluripotent stem cell-derived cardiomyocytes in a longterm culture. Circ J 77:1307-1314.
14. Otsuji TG, I Minami, Y Kurose, K Yamauchi, M Tada and N Nakatsuji. (2010). Progressive maturation in contracting cardiomyocytes derived from human embryonic stem cells: qualitative effects on electrophysiological responses to drugs. Stem Cell Res 4:201-213.
15. Lieu DK, JD Fu, N Chiamvimonvat, KC Tung, GP McNerney, T Huser, G Keller, CW Kong and RA Li. (2013). Mechanism-based facilitated maturation of human pluripotent stem cell-derived cardiomyocytes. Circ Arrhythm Electrophysiol 6:191-201.
16. Chan YC, S Ting, YK Lee, KM Ng, J Zhang, Z Chen, CW Siu, SK Oh and HF Tse. (2013). Electrical stimulation promotes maturation of cardiomyocytes derived from human embryonic stem cells. J Cardiovasc Transl Res 6:989-999.
17. Radisic M, H Park, H Shing, T Consi, FJ Schoen, R Langer, LE Freed and G Vunjak-Novakovic. (2004). Functional assembly of engineered myocardium by electrical stimulation of cardiac myocytes cultured on scaffolds. Proc Natl Acad Sci U S A 101:18129-18134.
18. Nunes SS, JW Miklas, J Liu, R Aschar-Sobbi, Y Xiao, B Zhang, J Jiang, S Massé, M Gagliardi, et al. (2013). Biowire: a platform for maturation of human pluripotent stem cell-derived cardiomyocytes. Nat Methods 10:781-787.
19. Hirt MN, J Boeddinghaus, A Mitchell, S Schaaf, C Börnchen, C Muller, H Schulz, N Hubner, J Stenzig, et al. (2014). Functional improvement and maturation of rat and human engineered heart tissue by chronic electrical stimulation. J Mol Cell Cardiol 74C:151-161.
20. Iglesias-Garcia O, S Baumgartner, L Macri-Pellizzeri, JR Rodriguez, G Abizanda, E Guruceaga, E Albiasu, D Corbacho, C Benavides-Vallve, et al. (2014). NRG-1b induces mature ventricular cardiac differentiation from induced pluripotent stem cells contributing to cardiac tissue repair. Stem Cells Dev [Epub ahead of print]; DOI: 10.1089/scd.2014.0211.
21. Kruger M, C Sachse, WH Zimmermann, T Eschenhagen, S Klede and WA Linke. (2008). Thyroid hormone regulates developmental titin isoform transitions via the phosphatidylinositol-3-kinase/AKT pathway. Circ Res 102:439-447.
22. Kensah G, LA Roa, J Dahlmann, R Zweigerdt, K Schwanke, J Hegermann, D Skvorc, A Gawol, A Azizian, et al. (2013). Murine and human pluripotent stem cellderived cardiac bodies form contractile myocardial tissue in vitro. Eur Heart J 34:1134-1146.
23. Mihic A, J Li, Y Miyagi, M Gagliardi, SH Li, J Zu, RD Weisel, G Keller and RK Li. (2014). The effect of cyclic stretch on maturation and 3D tissue formation of human embryonic stem cell-derived cardiomyocytes. Biomaterials 35:2798-2808.
24. Tulloch NL, V Muskheli, MV Razumova, FS Korte, M Regnier, KD Hauch, L Pabon, H Reinecke and CE Murry. (2011). Growth of engineered human myocardium with mechanical loading and vascular coculture. Circ Res 109:47-59.
25. Kim C, M Majdi, P Xia, KAWei, M Talantova, S Spiering, B Nelson, M Mercola and HS Chen. (2010). Non-cardiomyocytes influence the electrophysiological maturation of human embryonic stem cell-derived cardiomyocytes during differentiation. Stem Cells Dev 19:783-795.
26. Zhang D, IY Shadrin, J Lam, HQ Xian, HR Snodgrass and N Bursac. (2013). Tissue-engineered cardiac patch for advanced functional maturation of human ESC-derived cardiomyocytes. Biomaterials 34:5813-5820.
27. Rao C, T Prodromakis, L Kolker, UA Chaudhry, T Trantidou, A Sridhar, C Weekes, P Camelliti, SE Harding, et al. (2013). The effect of microgrooved culture substrates on calcium cycling of cardiac myocytes derived from human induced pluripotent stem cells. Biomaterials 34:2399-2411.
28. Hazeltine LB, CS Simmons, MR Salick, X Lian, MG Badur, W Han, SM Delgado, T Wakatsuki, WC Crone, BL Pruitt and SP Palecek. (2012). Effects of substrate mechanics on contractility of cardiomyocytes generated from human pluripotent stem cells. Int J Cell Biol 2012:508294.
29. Salick MR, BN Napiwocki, J Sha, GT Knight, SA Chindhy, TJ Kamp, RS Ashton and WC Crone. (2014). Micropattern width dependent sarcomere development in human ESCderived cardiomyocytes. Biomaterials 35:4454-4464.
30. Liu J, DK Lieu, CW Siu, JD Fu, HF Tse and RA Li. (2009). Facilitated maturation of Ca2 + handling properties of human embryonic stem cell-derived cardiomyocytes by calsequestrin expression. Am J Physiol Cell Physiol 297:C152-C159.
31. Chow MZ, L Geng, CW Kong, W Keung, JC Fung, KR Boheler and RA Li. (2013). Epigenetic regulation of the electrophysiological phenotype of human embryonic stem cell-derived ventricular cardiomyocytes: insights for driven maturation and hypertrophic growth. Stem Cells Dev 22:2678-2690.
32. Mitcheson JS, JC Hancox and AJ Levi. (1998). Cultured adult cardiac myocytes: future applications, culture methods, morphological and electrophysiological properties. Cardiovasc Res 39:280-300.
33. Mummery CL, OD Ward-van, P Doevendans, R Spijker, S van den Brink, R Hassink, M van der Heyden, T Opthof, M Pera, et al. (2003). Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells. Circulation 107:2733-2740.
34. Bird SD, PA Doevendans, MA van Rooijen, A Brutel de la Riviere, RJ Hassink, R Passier and CL Mummery. (2003). The human adult cardiomyocyte phenotype. Cardiovasc Res 58:423-434.
35. Maillet M, JH van Berlo and JD Molkentin. (2013). Molecular basis of physiological heart growth: fundamental concepts and new players. Nat Rev Mol Cell Biol 14:38-48.
36. Snir M, I Kehat, A Gepstein, R Coleman, J Itskovitz-Eldor, E Livne and L Gepstein. (2003). Assessment of the ultrastructural and proliferative properties of human embryonic stem cell-derived cardiomyocytes. Am J Physiol Heart Circ Physiol 285:H2355-H2363.
37. Peters NS, CR Green, PA Poole-Wilson and NJ Severs. (1993). Reduced content of connexin43 gap junctions in ventricular myocardium from hypertrophied and ischemic human hearts. Circulation 88:864-875.
38. Kim HD, DJ Kim, IJ Lee, BJ Rah, Y Sawa and J Schaper. (1992). Human fetal heart development after mid-term: morphometry and ultrastructural study. J Mol Cell Cardiol 24:949-965.
39. Mollova M, K Bersell, S Walsh, J Savla, LT Das, SY Park, LE Silberstein, CG Dos Remedios, D Graham, S Colan and B Kühn. (2013). Cardiomyocyte proliferation contributes to heart growth in young humans. Proc Natl Acad Sci U S A 110:1446-1451.
40. Olivetti G, E Cigola, R Maestri, D Corradi, C Lagrasta, SR Gambert and P Anversa. (1996). Aging, cardiac hypertrophy and ischemic cardiomyopathy do not affect the proportion of mononucleated and multinucleated myocytes in the human heart. J Mol Cell Cardiol 28:1463-1477.
41. Gregorio CC and PB Antin. (2000). To the heart of myofibril assembly. Trends Cell Biol 10:355-362.
42. Boateng SY and PH Goldspink. (2008). Assembly and maintenance of the sarcomere night and day. Cardiovasc Res 77:667-675.
43. Reiser PJ, MA Portman, XH Ning and C Schomisch Moravec. (2001). Human cardiac myosin heavy chain isoforms in fetal and failing adult atria and ventricles. Am J Physiol Heart Circ Physiol 280:H1814-H1820.
44. Xu XQ, SY Soo, W Sun and R Zweigerdt. (2009). Global expression profile of highly enriched cardiomyocytes derived from human embryonic stem cells. Stem Cells 27:2163-2174.
45. Hailstones D, P Barton, P Chan-Thomas, S Sasse, C Sutherland, E Hardeman and P Gunning. (1992). Differential regulation of the atrial isoforms of the myosin light chains during striated muscle development. J Biol Chem 267:23295-23300.
46. Macera MJ, P Szabo, R Wadgaonkar, MA Siddiqui and RS Verma. (1992). Localization of the gene coding for ventricular myosin regulatory light chain (MYL2) to human chromosome 12q23-q24.3. Genomics 13:829-831.
47. Linke WA and N Hamdani. (2014). Gigantic business: titin properties and function through thick and thin. Circ Res 114:1052-1068.
48. Neagoe C, M Kulke, MF del, JK Gwathmey, PP de Tombe, RJ Hajjar and WA Linke. (2002). Titin isoform switch in ischemic human heart disease. Circulation 106:1333-1341.
49. Opitz CA, MC Leake, I Makarenko, V Benes and WA Linke. (2004). Developmentally regulated switching of titin size alters myofibrillar stiffness in the perinatal heart. Circ Res 94:967-975.
50. Amin AS, HL Tan and AA Wilde. (2010). Cardiac ion channels in health and disease. Heart Rhythm 7:117-126.
51. Magyar J, N Iost, A Körtvély, T Bányász, L Virág, P Szigligeti, A Varró, M Opincariu, J Szécsi, JG Papp and PP Nánási. (2000). Effects of endothelin-1 on calcium and potassium currents in undiseased human ventricular myocytes. Pflugers Arch 441:144-149.
52. Ma J, L Guo, SJ Fiene, BD Anson, JA Thomson, TJ Kamp, KL Kolaja, BJ Swanson and CT January. (2011). High purity human-induced pluripotent stem cell-derived cardiomyocytes: electrophysiological properties of action potentials and ionic currents. Am J Physiol Heart Circ Physiol 301:H2006-H2017.
53. Synnergren J, C Améen, A Jansson and P Sartipy. (2012). Global transcriptional profiling reveals similarities and differences between human stem cell-derived cardiomyocyte clusters and heart tissue. Physiol Genomics 44:245-258.
54. Zhang J, GF Wilson, AG Soerens, CH Koonce, J Yu, SP Palecek, JA Thomson and TJ Kamp. (2009). Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ Res 104:e30-e41.
55. Drouin E, G Lande and F Charpentier. (1998). Amiodarone reduces transmural heterogeneity of repolarization in the human heart. J Am Coll Cardiol 32:1063-1067.
56. Verkerk AO, R Wilders, MM van Borren, RJ Peters, E Broekhuis, K Lam, R Coronel, JM de Bakker and HL Tan. (2007). Pacemaker current (If) in the human sinoatrial node. Eur Heart J 28:2472-2478.
57. Cordeiro JM, VV Nesterenko, S Sicouri, RJ Goodrow, Jr., JA Treat, M Desai, Y Wu, MX Doss, C Antzelevitch and JM Di Diego. (2013). Identification and characterization of a transient outward K+ current in human induced pluripotent stem cell-derived cardiomyocytes. J Mol Cell Cardiol 60:36-46.
58. Wang Y, H Xu, R Kumar, SM Tipparaju, MB Wagner and RW Joyner. (2003). Differences in transient outward current properties between neonatal and adult human atrial myocytes. J Mol Cell Cardiol 35:1083-1092.
59. Crumb WJ, Jr., JD Pigott and CW Clarkson. (1995). Comparison of Ito in young and adult human atrial myocytes: evidence for developmental changes. Am J Physiol 268:H1335-H1342.
60. Moretti A, M Bellin, A Welling, CB Jung, JT Lam, L Bott-Flugel, T Dorn, A Goedel, C Höhnke, et al. (2010). Patient-specific induced pluripotent stem-cell models for long-QT syndrome. N Engl J Med 363:1397-1409.
61. Nabauer M, DJ Beuckelmann, P Uberfuhr and G Steinbeck. (1996). Regional differences in current density and rate-dependent properties of the transient outward current in subepicardial and subendocardial myocytes of human left ventricle. Circulation 93:168-177.
62. Obreztchikova MN, EA Sosunov, A Plotnikov, EP Anyukhovsky, RZ Gainullin, P Danilo, ZH Yeom, RB Robinson and MR Rosen. (2003). Developmental changes in IKr and IKs contribute to age-related expression of dofetilide effects on repolarization and proarrhythmia. Cardiovasc Res 59:339-350.
63. Bkaily G, A Sculptoreanu, S Wang, M Nader, KM Hazzouri, D Jacques, D Regoli, P D'Orleans-Juste and L Avedanian. (2005). Angiotensin II-induced increase of Ttype Ca2 + current and decrease of L-type Ca2 + current in heart cells. Peptides 26:1410-1417.
64. Ono K and T Iijima. (2010). Cardiac T-type Ca(2 + ) channels in the heart. J Mol Cell Cardiol 48:65-70.
65. Fu JD, P Jiang, S Rushing, J Liu, N Chiamvimonvat and RA Li. (2010). Na+ /Ca2 + exchanger is a determinant of excitation-contraction coupling in human embryonic stem cell-derived ventricular cardiomyocytes. Stem Cells Dev 19:773-782.
66. Kleber AG and Y Rudy. (2004). Basic mechanisms of cardiac impulse propagation and associated arrhythmias. Physiol Rev 84:431-488.
67. Taggart P, PM Sutton, T Opthof, R Coronel, R Trimlett, W Pugsley and P Kallis. (2000). Inhomogeneous transmural conduction during early ischaemia in patients with coronary artery disease. J Mol Cell Cardiol 32:621-630.
68. Lee P, M Klos, C Bollensdorff, L Hou, P Ewart, TJ Kamp, J Zhang, A Bizy, G Guerrero-Serna, et al. (2012). Simultaneous voltage and calcium mapping of genetically purified human induced pluripotent stem cell-derived cardiac myocyte monolayers. Circ Res 110:1556-1563.
69. Chen SC, LM Davis, EM Westphale, EC Beyer and JE Saffitz. (1994). Expression of multiple gap junction proteins in human fetal and infant hearts. Pediatr Res 36:561-566.
70. Jansen JA, TA van Veen, JM de Bakker and HV van Rijen. (2010). Cardiac connexins and impulse propagation. J Mol Cell Cardiol 48:76-82.
71. Vreeker A, L van Stuijvenberg, TJ Hund, PJ Mohler, PG Nikkels and TA van Veen. (2014). Assembly of the cardiac intercalated disk during pre- and postnatal development of the human heart. PLoS One 9:e94722.
72. Wiegerinck RF, AO Verkerk, CN Belterman, TA van Veen, A Baartscheer, T Opthof, R Wilders, JM de Bakker and R Coronel. (2006). Larger cell size in rabbits with heart failure increases myocardial conduction velocity and QRS duration. Circulation 113:806-813.
73. Bers DM. (2002). Cardiac excitation-contraction coupling. Nature 415:198-205.
74. Beuckelmann DJ, M Näbauer and E Erdmann. (1992). Intracellular calcium handling in isolated ventricular myocytes from patients with terminal heart failure. Circulation 85:1046-1055.
75. Satin J, I Itzhaki, S Rapoport, EA Schroder, L Izu, G Arbel, R Beyar, CW Balke, J Schiller and L Gepstein. (2008). Calcium handling in human embryonic stem cellderived cardiomyocytes. Stem Cells 26:1961-1972.
76. Itzhaki I, S Rapoport, I Huber, I Mizrahi, L Zwi-Dantsis, G Arbel, J Schiller and L Gepstein. (2011). Calcium handling in human induced pluripotent stem cell derived cardiomyocytes. PLoS One 6:e18037.
77. Li S, G Chen and RA Li. (2013). Calcium signalling of human pluripotent stem cell-derived cardiomyocytes. J Physiol 591:5279-5290.
78. Liu J, JD Fu, CW Siu and RA Li. (2007). Functional sarcoplasmic reticulum for calcium handling of human embryonic stem cell-derived cardiomyocytes: insights for driven maturation. Stem Cells 25:3038-3044.
79. Binah O, K Dolnikov, O Sadan, M Shilkrut, N Zeevi-Levin, M Amit, A Danon and J Itskovitz-Eldor. (2007). Functional and developmental properties of human embryonic stem cells-derived cardiomyocytes. J Electrocardiol 40:S192-S196.
80. Zhu WZ, LF Santana and MA Laflamme. (2009). Local control of excitation-contraction coupling in human embryonic stem cell-derived cardiomyocytes. PLoS One 4:e5407.
81. Zhang XH, S Haviland, H Wei, T Saric, A Fatima, J Hescheler, L Cleemann and M Morad. (2013). Ca2 + signaling in human induced pluripotent stem cell-derived cardiomyocytes (iPS-CM) from normal and catecholaminergic polymorphic ventricular tachycardia (CPVT)-afflicted subjects. Cell Calcium 54:57-70.
82. Taylor DG, LD Parilak, MM LeWinter and HJ Knot. (2004). Quantification of the rat left ventricle force and Ca2 + -frequency relationships: similarities to dog and human. Cardiovasc Res 61:77-86.
83. Ferrantini C, C Crocini, R Coppini, F Vanzi, C Tesi, E Cerbai, C Poggesi, FS Pavone and L Sacconi. (2013). The transverse-axial tubular system of cardiomyocytes. Cell Mol Life Sci 70:4695-4710.
84. Dolnikov K, M Shilkrut, N Zeevi-Levin, S Gerecht-Nir, M Amit, A Danon, J Itskovitz-Eldor and O Binah. (2006). Functional properties of human embryonic stem cellderived cardiomyocytes: intracellular Ca2 + handling and the role of sarcoplasmic reticulum in the contraction. Stem Cells 24:236-245.
85. Qu Y, A Ghatpande, N El-Sherif and M Boutjdir. (2000). Gene expression of Na+ /Ca2 + exchanger during development in human heart. Cardiovasc Res 45:866-873.
86. Schaaf S, A Shibamiya, M Mewe, A Eder, A Stohr, MN Hirt, T Rau, WH Zimmermann, L Conradi, T Eschenhagen and A Hansen. (2011). Human engineered heart tissue as a versatile tool in basic research and preclinical toxicology. PLoS One 6:e26397.
87. Holubarsch C, J Ludemann, S Wiessner, T Ruf, H Schulte-Baukloh, S Schmidt-Schweda, B Pieske, H Posival and H Just. (1998). Shortening versus isometric contractions in isolated human failing and non-failing left ventricular myocardium: dependency of external work and force on muscle length, heart rate and inotropic stimulation. Cardiovasc Res 37:46-57.
88. Mulieri LA, G Hasenfuss, B Leavitt, PD Allen and NR Alpert. (1992). Altered myocardial force-frequency relation in human heart failure. Circulation 85:1743-1750.
89. Wiegerinck RF, A Cojoc, CM Zeidenweber, G Ding, M Shen, RW Joyner, JD Fernandez, KR Kanter, PM Kirshbom, BE Kogon and MB Wagner. (2009). Force frequency relationship of the human ventricle increases during early postnatal development. Pediatr Res 65:414-419.
90. Chang TD and GR Cumming. (1972). Chronotropic responses of human heart tissue cultures. Circ Res 30:628-633.
91. Pillekamp F, M Haustein, M Khalil, M Emmelheinz, R Nazzal, R Adelmann, F Nguemo, O Rubenchyk, K Pfannkuche, et al. (2012). Contractile properties of early human embryonic stem cell-derived cardiomyocytes: beta-adrenergic stimulation induces positive chronotropy and lusitropy but not inotropy. Stem Cells Dev 21:2111-2121.
92. Brito-Martins M, SE Harding and NN Ali. (2008). b1- and b2-adrenoceptor responses in cardiomyocytes derived from human embryonic stem cells: comparison with failing and non-failing adult human heart. Br J Pharmacol 153:751-759.
93. Germanguz I, O Sedan, N Zeevi-Levin, R Shtrichman, E Barak, A Ziskind, S Eliyahu, G Meiry, M Amit, J Itskovitz-Eldor and O Binah. (2011). Molecular characterization and functional properties of cardiomyocytes derived from human inducible pluripotent stem cells. J Cell Mol Med 15:38-51.
94. O'Connell TD, BC Jensen, AJ Baker and PC Simpson. (2014). Cardiac alpha1-adrenergic receptors: novel aspects of expression, signaling mechanisms, physiologic function, and clinical importance. Pharmacol Rev 66:308-333.
95. Földes G, E Matsa, J Kriston-Vizi, T Leja, S Amisten, L Kolker, T Kodagoda, NF Dolatshad, M Mioulane, et al. (2014). Aberrant a-Adrenergic hypertrophic response in cardiomyocytes from human induced pluripotent cells. Stem Cell Reports 3:905-914.
96. Földes G, M Mioulane, JS Wright, AQ Liu, P Novak, B Merkely, J Gorelik, MD Schneider, NN Ali and SE Harding. (2011). Modulation of human embryonic stem cell-derived cardiomyocyte growth: a testbed for studying human cardiac hypertrophy? J Mol Cell Cardiol 50:367-376.
97. Schaper J, F Schwarz, H Kittstein, E Kreisel, B Winkler and FW Hehrlein. (1980). Ultrastructural evaluation of the effects of global ischemia and reperfusion on human myocardium. Thorac Cardiovasc Surg 28:337-342.
98. Lopaschuk GD and JS Jaswal. (2010). Energy metabolic phenotype of the cardiomyocyte during development, differentiation, and postnatal maturation. J Cardiovasc Pharmacol 56:130-140.
99. Lopaschuk GD, RL Collins-Nakai and T Itoi. (1992). Developmental changes in energy substrate use by the heart. Cardiovasc Res 26:1172-1180.
100. Birket MJ, S Casini, G Kosmidis, DA Elliott, AA Gerencser, A Baartscheer, C Schumacher, PG Mastroberardino, AG Elefanty, EG Stanley and CL Mummery. (2013). PGC-1a and reactive oxygen species regulate human embryonic stem cell-derived cardiomyocyte function. Stem Cell Reports 1:560-574.
101. Kim C, J Wong, J Wen, S Wang, C Wang, S Spiering, NG Kan, S Forcales, PL Puri, et al. (2013). Studying arrhythmogenic right ventricular dysplasia with patientspecific iPSCs. Nature 494:105-110.
102. Martherus RS, SJ Vanherle, ED Timmer, VA Zeijlemaker, JL Broers, HJ Smeets, JP Geraedts and TA Ayoubi. (2010). Electrical signals affect the cardiomyocyte transcriptome independently of contraction. Physiol Genomics 42A:283-289.
103. Serena E, E Figallo, N Tandon, C Cannizzaro, S Gerecht, N Elvassore and G Vunjak-Novakovic. (2009). Electrical stimulation of human embryonic stem cells: cardiac differentiation and the generation of reactive oxygen species. Exp Cell Res 315:3611-3619.
104. Hernandez-Garcia D, CD Wood, S Castro-Obregon and L Covarrubias. (2010). Reactive oxygen species: a radical role in development? Free Radic Biol Med 49:130-143.
105. Shyu KG. (2009). Cellular and molecular effects of mechanical stretch on vascular cells and cardiac myocytes. Clin Sci (Lond) 116:377-389.
106. Frank D, C Kuhn, B Brors, C Hanselmann, M Ludde, HA Katus and N Frey. (2008). Gene expression pattern in biomechanically stretched cardiomyocytes: evidence for a stretch-specific gene program. Hypertension 51:309-318.
107. Pong T, WJ Adams, MA Bray, AW Feinberg, SP Sheehy, AA Werdich and KK Parker. (2011). Hierarchical architecture influences calcium dynamics in engineered cardiac muscle. Exp Biol Med (Maywood) 236:366-373.
108. Yamada K, KG Green, AM Samarel and JE Saffitz. (2005). Distinct pathways regulate expression of cardiac electrical and mechanical junction proteins in response to stretch. Circ Res 97:346-353.
109. Sadoshima J, Y Xu, HS Slayter and S Izumo. (1993). Autocrine release of angiotensin II mediates stretchinduced hypertrophy of cardiac myocytes in vitro. Cell 75:977-984.
110. Shyu KG, WH Ko, WS Yang, BW Wang and P Kuan. (2005). Insulin-like growth factor-1 mediates stretchinduced upregulation of myostatin expression in neonatal rat cardiomyocytes. Cardiovasc Res 68:405-414.
111. Leychenko A, E Konorev, M Jijiwa and ML Matter. (2011). Stretch-induced hypertrophy activates NFkBmediated VEGF secretion in adult cardiomyocytes. PLoS One 6:e29055.
112. Seko Y, Y Seko, N Takahashi, M Shibuya and Y Yazaki. (1999). Pulsatile stretch stimulates vascular endothelial growth factor (VEGF) secretion by cultured rat cardiac myocytes. Biochem Biophys Res Commun 254:462-465.
113. Haggart CR, EG Ames, JK Lee and JW Holmes. (2014). Effects of stretch and shortening on gene expression in intact myocardium. Physiol Genomics 46:57-65.
114. Shimko VF and WC Claycomb. (2008). Effect of mechanical loading on three-dimensional cultures of embryonic stem cell-derived cardiomyocytes. Tissue Eng Part A 14:49-58.
115. Kreutzer J, L Ikonen, J Hirvonen, M Pekkanen-Mattila, K Aalto-Setälä and P Kallio. (2013). Pneumatic cell stretching system for cardiac differentiation and culture. Med Eng Phys 36:496-501.
116. Forhead AJ and AL Fowden. (2014). Thyroid hormones in fetal growth and prepartum maruration. J Endocrinol 221:R87-R103.
117. Chattergoon NN,GDGiraud, S Louey, P Stork,ALFowden and KL Thornburg. (2012). Thyroid hormone drives fetal cardiomyocyte maturation. FASEB J 26:397-408.
118. Van Tuyl M, PE Blommaart, PA de Boer, SE Wert, JM Ruijter, S Islam, J Schnitzer, AR Ellison, D Tibboel, AF Moorman and WH Lamers. (2004). Prenatal exposure to thyroid hormone is necessary for normal postnatal development of murine heart and lungs. Dev Biol 272:104-117.
119. Yang X, M Rodriguez, L Pabon, KA Fischer, H Reinecke, M Regnier, NJ Sniadecki, H Ruohola-Baker and CE Murry. (2014). Tri-iodo-l-thyronine promotes the maturation of human cardiomyocytes-derived from induced pluripotent stem cells. J Mol Cell Cardiol 72:296-304.
120. Lee YK, KM Ng, YC Chan, WH Lai, KW Au, CY Ho, LY Wong, CP Lau, HF Tse and CW Siu. (2010). Triiodothyronine promotes cardiac differentiation and maturation of embryonic stem cells via the classical genomic pathway. Mol Endocrinol 24:1728-1736.
121. Takahashi T, B Lord, PC Schulze, RM Fryer, SS Sarang, SR Gullans and RT Lee. (2003). Ascorbic acid enhances differentiation of embryonic stem cells into cardiac myocytes. Circulation 107:1912-1916.
122. Cao N, Z Liu, Z Chen, J Wang, T Chen, X Zhao, Y Ma, L Qin, J Kang, et al. (2012). Ascorbic acid enhances the cardiac differentiation of induced pluripotent stem cells through promoting the proliferation of cardiac progenitor cells. Cell Res 22:219-236.
123. Baharvand H, M Azarnia, K Parivar and SK Ashtiani. (2005). The effect of extracellular matrix on embryonic stem cell-derived cardiomyocytes. J Mol Cell Cardiol 38:495-503.
124. Zhu WZ, Y Xie, KW Moyes, JD Gold, B Askari and MA Laflamme. (2010). Neuregulin/ErbB signaling regulates cardiac subtype specification in differentiating human embryonic stem cells. Circ Res 107:776-786.
125. Ou DB, Y He, R Chen, JW Teng, HT Wang, D Zeng, XT Liu, L Ding, JY Huang and QS Zheng. (2011). Threedimensional co-culture facilitates the differentiation of embryonic stem cells into mature cardiomyocytes. J Cell Biochem 112:3555-3562.
126. Blin G, D Nury, S Stefanovic, T Neri, O Guillevic, B Brinon, V Bellamy, C Rucker-Martin, P Barbry, et al. (2010). A purified population of multipotent cardiovascular progenitors derived from primate pluripotent stem cells engrafts in postmyocardial infarcted nonhuman primates. J Clin Invest 120:1125-1139.
127. Thavandiran N, N Dubois, A Mikryukov, S Masse, B Beca, CA Simmons, VS Deshpande, JP McGarry, CS Chen, et al. (2013). Design and formulation of functional pluripotent stem cell-derived cardiac microtissues. Proc Natl Acad Sci U S A 110:E4698-E4707.
128. Kelm JM, E Ehler, LK Nielsen, S Schlatter, JC Perriard and M Fussenegger. (2004). Design of artificial myocardial microtissues. Tissue Eng 10:201-214.
129. Eschenhagen T, C Fink, U Remmers, H Scholz, J Wattchow, J Weil, W Zimmermann, HH Dohmen, H Schäfer, et al. (1997). Three-dimensional reconstitution of embryonic cardiomyocytes in a collagen matrix: a new heart muscle model system. FASEB J 11:683-694.
130. Zimmermann WH, K Schneiderbanger, P Schubert, M Didié, FMünzel, JF Heubach, S Kostin, WL Neuhuber and T Eschenhagen. (2002). Tissue engineering of a differentiated cardiac muscle construct. Circ Res 90:223-230.
131. de Lange WJ, LF Hegge, AC Grimes, CW Tong, TM Brost, RL Moss and JC Ralphe. (2011). Neonatal mousederived engineered cardiac tissue: a novel model system for studying genetic heart disease. Circ Res 109:8-19.
132. Caspi O, A Lesman, Y Basevitch, A Gepstein, G Arbel, IH Habib, L Gepstein and S Levenberg. (2007). Tissue engineering of vascularized cardiac muscle from human embryonic stem cells. Circ Res 100:263-272.
133. Kawamura M, S Miyagawa, K Miki, A Saito, S Fukushima, T Higuchi, T Kawamura, T Kuratani, T Daimon, et al. (2012). Feasibility, safety, and therapeutic efficacy of human induced pluripotent stem cell-derived cardiomyocyte sheets in a porcine ischemic cardiomyopathy model. Circulation 126:S29-S37.
134. Streckfuss-Bomeke K, F Wolf, A Azizian, M Stauske, M Tiburcy, S Wagner, D Hubscher, R Dressel, S Chen, et al. (2013). Comparative study of human-induced pluripotent stem cells derived from bone marrow cells, hair keratinocytes, and skin fibroblasts. Eur Heart J 34:2618-2629.
135. McDonald TF, HG Sachs and RL DeHaan. (1972). Development of sensitivity to tetrodotoxin in beating chick embryo hearts, single cells, and aggregates. Science 176: 1248-1250.
136. Tiburcy M, M Didié, O Boy, P Christalla, S Döker, H Naito, BC Karikkineth, A El-Armouche, M Grimm, et al. (2011). Terminal differentiation, advanced organotypic maturation, and modeling of hypertrophic growth in engineered heart tissue. Circ Res 109:1105-1114.
137. Zhang J, M Klos, GF Wilson, AM Herman, X Lian, KK Raval, MR Barron, L Hou, AG Soerens, et al. (2012). Extracellular matrix promotes highly efficient cardiac differentiation of human pluripotent stem cells: the matrix sandwich method. Circ Res 111:1125-1136.
138. Lanasa SM and SJ Bryant. (2009). Influence of ECM proteins and their analogs on cells cultured on 2-D hydrogels for cardiac muscle tissue engineering. Acta Biomater 5:2929-2938.
139. Larsen M, VV Artym, JA Green and KM Yamada. (2006). The matrix reorganized: extracellular matrix remodeling and integrin signaling. Curr Opin Cell Biol 18:463-471.
140. Jacot JG, AD McCulloch and JH Omens. (2008). Substrate stiffness affects the functional maturation of neonatal rat ventricular myocytes. Biophys J 95:3479-3487.
141. Engler AJ, C Carag-Krieger, CP Johnson, M Raab, HY Tang, DW Speicher, JW Sanger, JM Sanger and DE Discher. (2008). Embryonic cardiomyocytes beat best on a matrix with heart-like elasticity: scar-like rigidity inhibits beating. J Cell Sci 121:3794-3802.
142. Yin L, H Bien and E Entcheva. (2004). Scaffold topography alters intracellular calcium dynamics in cultured cardiomyocyte networks. Am J Physiol Heart Circ Physiol 287:H1276-H1285.
143. VanWinkle WB, MB Snuggs and LM Buja. (1996). Cardiogel: a biosynthetic extracellular matrix for cardiomyocyte culture. In Vitro Cell Dev Biol Anim 32:478-485.
144. Bick RJ, MB Snuggs, BJ Poindexter, LM Buja and WB van Winkle. (1998). Physical, contractile and calcium handling properties of neonatal cardiac myocytes cultured on different matrices. Cell Adhes Commun 6:301-310.
145. Davis RA, WB van Winkle, LM Buja, BJ Poindexter and RJ Bick. (2006). Effect of a simple versus a complex matrix on the polarity of cardiomyocytes in culture. J Burns Wounds 5:e3.
146. RodriguezAG, SJHan,MRegnier andNJ Sniadecki. (2011). Substrate stiffness increases twitch power of neonatal cardiomyocytes in correlation with changes in myofibril structure and intracellular calcium. Biophys J 101:2455-2464.
147. Bhana B, RK Iyer, WL Chen, R Zhao, KL Sider, M Likhitpanichkul, CA Simmons and M Radisic. (2010). Influence of substrate stiffness on the phenotype of heart cells. Biotechnol Bioeng 105:1148-1160.
148. Galie PA, N Khalid, KE Carnahan, MV Westfall and JP Stegemann. (2013). Substrate stiffness affects sarcomere and costamere structure and electrophysiological function of isolated adult cardiomyocytes. Cardiovasc Pathol 22:219-227.
149. Jacot JG, H Kita-Matsuo, KA Wei, HS Chen, JH Omens, M Mercola and AD McCulloch. (2010). Cardiac myocyte force development during differentiation and maturation. Ann N Y Acad Sci 1188:121-127.
150. McDevitt TC, JC Angello, ML Whitney, H Reinecke, SD Hauschka, CE Murry and PS Stayton. (2002). In vitro generation of differentiated cardiacmyofibers onmicropatterned laminin surfaces. J Biomed Mater Res 60:472-479.
151. Feinberg AW, PW Alford, H Jin, CM Ripplinger, AA Werdich, SP Sheehy, A Grosberg and KK Parker. (2012). Controlling the contractile strength of engineered cardiac muscle by hierarchal tissue architecture. Biomaterials 33:5732-5741.
152. Fu JD, SN Rushing, DK Lieu, CW Chan, CW Kong, L Geng, KD Wilson, N Chiamvimonvat, KR Boheler, et al. (2011). Distinct roles of microRNA-1 and - 499 in ventricular specification and functional maturation of human embryonic stem cell-derived cardiomyocytes. PLoS One 6:e27417.
153. Tingare A, B Thienpont and HL Roderick. (2013). Epigenetics in the heart: the role of histone modifications in cardiac remodelling. Biochem Soc Trans 41:789-796.
154. Bett GC, AD Kaplan, A Lis, TR Cimato, ES Tzanakakis, Q Zhou, MJ Morales and RL Rasmusson. (2013). Electronic "expression" of the inward rectifier in cardiocytes derived from human-induced pluripotent stem cells. Heart Rhythm 10:1903-1910.
155. Hoekstra M, CL Mummery, AAM Wilde, CR Bezzina and AO Verkerk. (2012). Induced pluripotent stem cell derived cardiomyocytes as models for cardiac arrhythmias. Front Physiol 3:346.
156. Prigodich AE, PS Randeria, WE Briley, NJ Kim, WL Daniel, DA Giljohann and CA Mirkin. (2012). Multiplexed nanoflares: mRNA detection in live cells. Anal Chem 84:2062-2066.
157. Mehta A, GL Sequiera, CJ Ramachandra, Y Sudibyo, Y Chung, J Sheng, KY Wong, TH Tan, P Wong, R Liew and W Shim. (2014). Re-trafficking of hERG reverses long QT syndrome 2 phenotype in human iPS-derived cardiomyocytes. Cardiovasc Res 102:497-506.
158. Rana P, B Anson, S Engle and Y Will. (2012). Characterization of human-induced pluripotent stem cellderived cardiomyocytes: bioenergetics and utilization in safety screening. Toxicol Sci 130:117-131.
159. Gaspar JA, MX Doss, JG Hengstler, C Cadenas, J Hescheler and A Sachinidis. (2014). Unique metabolic features of stem cells, cardiomyocytes, and their progenitors. Circ Res 114:1346-1360.
160. Montessuit C, T Palma, C Viglino, C Pellieux and R Lerch. (2006). Effects of insulin-like growth factor-I on the maturation of metabolism in neonatal rat cardiomyocytes. Pflugers Arch 452:380-386.
161. Knollmann BC. (2013). Induced pluripotent stem cellderived cardiomyocytes: boutique science or valuable arrhythmia model? Circ Res 112:969-976.
162. Pohjoismäki JL, M Krüger, N Al-Furoukh, A Lagerstedt, PJ Karhunen and T Braun. (2013). Postnatal cardiomyocyte growth and mitochondrial reorganization cause multiple changes in the proteome of human cardiomyocytes. Mol Biosyst 9:1210-1219.